Google’s Jeff Dean: AI Search relies on classic ranking and retrieval

Behind the AI interface, a staged system narrows tens of thousands of documents to a few, showing that visibility hinges on ...
Communications of the ACM

Formal Reasoning Meets LLMs: Toward AI for Mathematics and Verification

A marriage of formal methods and LLMs seeks to harness the strengths of both.
The New York Times

There’s a New American TikTok. What Does That Mean for You?

The popular short form video app has a new corporate structure in the United States, which could result in some changes for the 200 million Americans who use TikTok. By Emmett Lindner TikTok has new ...
Seeking Alpha

Recursion Pharmaceuticals, Inc. (RXRX) Discusses Updated Safety and Efficacy Data from TUPELO Phase I/II Study of REC-4881 in FAP Transcript

Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...
IEEE

A Data-Driven Control Algorithm With Time Delay Compensation Based on Optimized Recursive Adaptive Identification for Magnetic Levitation Systems

Abstract: This study addresses the challenge of precise control of the maglev system under the condition of rapid time-varying dynamics and large time delay. Maglev technology has been applied in many ...
Nasdaq

MIT and Recursion Unveil Boltz-2: A Revolutionary Open-Source Biomolecular Co-Folding Model with Advanced Structure and Binding Affinity Prediction

Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
Nasdaq

Recursion to Present Preliminary Data on REC-4881 for Familial Adenomatous Polyposis at Digestive Disease Week 2025

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...
TMCnet

HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data

PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading ...
Forbes

Beyond The Algorithm: Why Data Governance Is Key To Pharma's AI Future

The pharmaceutical industry is on the cusp of an AI-driven revolution. By 2030, AI-powered drug discovery is projected to be a $9.1 billion market, growing at a staggering 29.7% CAGR. AI promises to ...
Seeking Alpha

Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse events In comparison to placebo, treatment with REC-994 400 mg showed ...